Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging
NCT04946383
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Aging
Interventions
DRUG:
Dasatinib plus Quercetin
Sponsor
TruDiagnostic